Comparative Efficacy of ARNI Versus ACE Inhibitor Therapy in Egyptian Children With Dilated Cardiomyopathy
NCT07197372 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 70
Last updated 2025-09-29
Summary
This is a prospective, cohort study designed to evaluate the efficacy and safety of sacubitril/valsartan versus captopril in children with dilated cardiomyopathy (DCM) admitted to Assiut University Children Hospital over a one-year period.
Conditions
- ARNI
- Pediatric Dilated Cardiomyopathy
- ACE Inhibitor
Sponsors & Collaborators
-
Assiut University
lead OTHER
Eligibility
- Min Age
- 1 Month
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-05-30
- Primary Completion
- 2027-05-30
- Completion
- 2027-12-30
More Related Trials
-
Sacubitril-valsartan in Patients With Heart Failure.
NCT07341893 ·Status: COMPLETED ·Phase: NA
-
Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF
NCT03785405 ·Status: COMPLETED ·Phase: PHASE3
-
ARNI Versus plAcebo in Patients With Congenital sYStemic Right Ventricle Heart Failure
NCT05117736 ·Status: TERMINATED ·Phase: NA
-
Cardioprotection on Chemotherapy-Induced Cardiotoxicity
NCT06853951 ·Status: RECRUITING ·Phase: PHASE3
-
Sacubitril/Valsartan in Patients With Prosthetic Heart Valves With Heart Failure and Reduced Ejection Fraction
NCT07192341 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of Sotalol in Children With Arrhythmia
NCT03895411 ·Status: UNKNOWN ·Phase: PHASE4
-
Natriuretic Peptides as a Prognostic and Risk Stratification Tool in Assessment of Valvular Heart Disease
NCT05439369 ·Status: UNKNOWN
-
Comparison of BNP and NT-proBNP in the Management of Patients With Chronic and Acute Heart Failure
NCT04107220 ·Status: UNKNOWN ·Phase: NA
-
Dobutamine Versus Milrinone in Management of Critically Ill Low Cardiac Output Pediatric Patients at Cairo University Children's Hospital
NCT05999487 ·Status: UNKNOWN ·Phase: NA
-
Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
NCT01917149 ·Status: COMPLETED ·Phase: PHASE4
-
Role of Sacubitril/Valsartan in the Improvement of Heart Failure With Reduced Ejection Fraction
NCT04397302 ·Status: COMPLETED
-
Effects of Sacubitril/Valsartan on Exercise Capacity, Natriuretic Peptides and Ventricular Remodeling in Heart Failure
NCT04434170 ·Status: COMPLETED
-
Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD
NCT04197050 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of the Sodium-glucose Cotransporter 2 Inhibitors+Sacubitril/Valsartan Therapy in Patients With HFrEF.
NCT05934071 ·Status: UNKNOWN
-
Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation
NCT04687111 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem
NCT00319982 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Orodispersible Minitablets of Enalapril in Children With Heart Failure Due to Dilated Cardiomyopathy
NCT02652728 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Ambrisentan in Single Ventricle
NCT02080637 ·Status: COMPLETED ·Phase: PHASE2
-
Is Sacubitril-valsartan Superior to Dapagliflozin in Improving Myocardial Function Performance
NCT06090487 ·Status: COMPLETED ·Phase: NA
-
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)
NCT05714085 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Real-world Research : Assessment of Effect of Combination of Drugs in the Treatment of Heart Failure
NCT06158711 ·Status: NOT_YET_RECRUITING
-
The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure
NCT04688294 ·Status: COMPLETED ·Phase: PHASE4
-
" Evaluation of Safety and Efficacy of Empagliflozin and Sacubitril/Valsartan for CHF With Reduced Ejection Fraction in ACHD "
NCT05580510 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Cohort Study to Compare the Hospitalization Between Naive Sacubitril/Valsartan and Naive ACEi/ARBs Heart Failure Patients With Reduced Ejection Fraction Using Secondary US Electronic Health Records Data
NCT05096143 ·Status: COMPLETED
-
Follow-up Safety Trial in Children With Chronic Heart Failure Therapy Receiving Orodispersible Minitablets of Enalapril
NCT02654678 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3